AntiDiabetic Cancer Research Results
AntiDiabetic, AntiDiabetic: Click to Expand ⟱
| Source: |
| Type: |
AntiDiabetic
|
Lung, Lung Cancer: Click to Expand ⟱
Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4)
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
CRC, |
DLD1 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Liver, |
HUH7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
*antiOx↑, *AntiBio↑, *AntiDiabetic↑, *AntiCan↑, Dose↝, TumCP↓, ER Stress↑, Apoptosis↑, Bcl-2↓, BAX↑, Casp3↑, Casp9↑, Casp12↝, NF-kB↓, P53↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 1, Casp12↝, 1, Casp3↑, 1, Casp9↑, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1,
Migration(tgid=13) ⓘ
TumCP↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
Dose↝, 1,
Total Targets: 11
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiBio↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiDiabetic↑, 1,
Total Targets: 4
Scientific Paper Hit Count for: AntiDiabetic, AntiDiabetic
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:1385 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page